Optos

Optos is a pioneer and leader in ultra-widefield retinal imaging, having developed the proprietary optomap technology that captures a 200-degree view of the retina in a single, non-contact shot. Acquired by Nikon Corporation in 2015, the company has a strong commercial footprint with over 16,000 devices installed and more than 150 million patients imaged. Its technology is supported by extensive clinical validation, including studies showing equivalence to the ETDRS gold standard for diabetic retinopathy, and is increasingly integrated with advanced software and cloud-based data management solutions.

Proprietary ultra-widefield (UWF) scanning laser ophthalmoscopy (SLO) capable of capturing a 200-degree, single-shot retinal image. Platform includes multimodal imaging (color, autofluorescence, angiography), integrated OCT (via Monaco device), and cloud-based software (OptosCloud) for image management and analysis.

Optos competes in the premium retinal imaging market against major players like Zeiss, Heidelberg Engineering, Topcon, and Nidek. Its key differentiator is its proprietary 200-degree single-shot UWF technology, though competitors offer alternative widefield and multimodal imaging solutions.